Literature DB >> 12096014

Assay of teicoplanin in serum: comparison of high-performance liquid chromatography and fluorescence polarization immunoassay.

Steven J McCann1, Leslie O White, Brian Keevil.   

Abstract

A simple liquid extraction coupled with reverse-phase HPLC and UV detection was shown to correlate well with fluorescence polarization immunoassay (FPIA) on the Abbott TD(x) analyser for serum teicoplanin analysis, r(2) = 0.974, HPLC = 0.908 TDx + 2.324. A Bland-Altman plot showed no significant bias between the results. The HPLC method was linear over the range 10-100 mg/L. The HPLC method showed very good reproducibility, comparable to FPIA. The inter-assay coefficients of variation were 2.76%, 2.29% and 2.65% at 10.3, 51.4 and 77.1 mg/L, respectively, with intra-assay coefficients of variation of 1.86%, 1.97% and 1.17% at 9.13, 50.65 and 75.1 mg/L, respectively. Recoveries were between 99.1 and 101.8% within the analytical range. The HPLC method described is simple, robust, highly reproducible and suited to a clinical laboratory with the appropriate equipment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096014     DOI: 10.1093/jac/dkf067

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.

Authors:  Jasmin Hum; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2012-02-24       Impact factor: 3.896

2.  Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of teicoplanin concentrations in human plasma.

Authors:  Eric Dailly; François Fraissinet; Guillaume Deslandes; Régis Bouquié; Pascale Jolliet
Journal:  J Clin Lab Anal       Date:  2013-02-01       Impact factor: 2.352

3.  Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.

Authors:  Wei-Tao Jia; Qiang Fu; Wen-Hai Huang; Chang-Qing Zhang; Mohamed N Rahaman
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

4.  Quantification of Teicoplanin Using the HPLC-UV Method for Clinical Applications in Critically Ill Patients in Korea.

Authors:  Jaeok Lee; Eun-Kyoung Chung; Sung-Wook Kang; Hwa-Jeong Lee; Sandy-Jeong Rhie
Journal:  Pharmaceutics       Date:  2021-04-17       Impact factor: 6.321

5.  A novel sensitive analytical method for the simultaneous analysis of vancomycin and teicoplanin in human urine via single high-performance liquid chromatography coupled with photodiode array and mass spectrometry in series.

Authors:  Maria Giakoumaki; Yiannis Sarigiannis; Evroula Hapeshi
Journal:  J Sep Sci       Date:  2022-05-20       Impact factor: 3.614

6.  A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis.

Authors:  Hao Ding; Cun-Ju Zhao; Xu Cui; Yi-Fei Gu; Wei-Tao Jia; Mohamed N Rahaman; Yang Wang; Wen-Hai Huang; Chang-Qing Zhang
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.